
TSE:SLF
This summary was created by AI, based on 12 opinions in the last 12 months.
Sun Life Financial Inc. (SLF) is seen as a generally solid investment by various experts, although the performance and outlook differ among analysts. Some highlight that SLF trades at a lower price-to-earnings ratio compared to Canadian banks and has demonstrated decent ROE figures, albeit with some recent challenges in its dental business in the U.S. Analysts suggest holding onto SLF, given its long-term growth potential, particularly in Asian markets, and its consistent dividend growth. Despite the positive aspects, there are concerns about current valuations, with some experts seeing it as not cheap relative to book value and growth expectations. Overall, the consensus indicates a bias towards maintaining existing positions while being cautious about new investments.
He likes the life insurance industry and owns three companies in that space. Sun Life is the Canadian company that he likes. He prefers it to Manulife. He thinks it is better managed, with better exposure to interest rates. He likes the amount and quality of international diversification of Sun Life.
Life Insurance companies do better when interest rates rise because they reinvest their premiums, mainly in the bond market. Interest rates have not increased as much as he hoped; instead, the yield curve is flattening. He expects interest rates to rise in the future, though, and he owns Sun Life in that expectation. He thinks that over the near term, Sun Life will perform better than the Canadian banks as interest rates move up. Interest rates will rise because the economy is doing better and inflation is coming back, caused by labour shortages and tariffs.
Manulife (MFC-T) versus Sunlife (SLF-T). He owned Manulife going into the financial crisis, but became concerned about management and sold out of their holdings. When Sunlife began to fall in sympathy they bought them – focusing on the preferred shares in particular. Manulife still has some questionable assets in the US and may not know how to offload them.
He likes lifecos for the long haul because society is aging for longer, so the lifecos defer their payouts longer. However, profitability in this business lies in the long-term disability sector, but no company now has a competitive advantage here. Look out for the one that does by reading their reports for what they say about disability insurance management.
He considers this a healthy yield that is likely to grown. It trades at only 11x earnings. It will be a beneficiary of rising interest rates, which he expects to continue. He expects 10% earnings growth for the next 3 years. This is the largest foreign insurer in Asia (India), which offers huge growth possibilities. Its MFS American operations have turned around. Yield 3.8%. (Analysts’ price target $58.54)